Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 35

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 35
---
 the closing bid price of the Company’s Class A Ordinary Shares
is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide the Company written confirmation of compliance with
this requirement, as applicable. On February 11, 2025, the Company effected a 1-for-20 reverse stock split of its issued and unissued
shares. The effect of the reverse stock split was to consolidate every 20 issued and unissued share into one share. On February 27, 2025,
the Company received a notification letter from Nasdaq, indicating that the closing bid price of the Company’s securities had been
at $1.00 per share or greater for 10 consecutive business days from February 11, 2025 to February 26, 2025, and the Company had regained
compliance with the Minimum Bid Price Rule.

On May 24, 2024, the
Company received a deficiency letter (“MVLS Deficiency Letter”) from the Staff of Nasdaq notifying the Company that, for
the preceding 35 consecutive business days, the Class A Shares did not meet the minimum $50,000,000 Market Value of Listed
Securities requirement (“MVLS Requirement”) for continued listing on Nasdaq pursuant to Nasdaq Listing Rules
5450(b)(2)(A) (the “MVLS Requirement,” and the Company’s non-compliance with this requirement, the “MVLS
Deficiency”). In accordance with Nasdaq Rule 5810(c)(3)(C), the Company has been provided an initial period of 180 calendar
days, or until November 20, 2024 (the “Compliance Date”), to regain compliance with the MVLS Requirement. If, at any
time before the Compliance Date, the MVLS for the Class A Shares is at least $50,000,000 for a minimum of ten consecutive business
days, the Staff will provide the Company written confirmation of compliance with the MVLS Requirement. In the event the Company does
not regain compliance with the above requirement prior to the expiration of the compliance period, it will receive written
notification that its securities are subject to delisting.

On May 24, 2024, the Company
received a deficiency letter (“MVPHS Deficiency Letter”) from the Staff of Nasdaq notifying the Company that, for the preceding
35 consecutive business days, the Company’s Class A Ordinary Shares did not meet the minimum $15,000,000 Market Value of Publicly
H